Drug intelligence / Profile preview

shenfuqiangxin

Development stage
Unknown
Lead developer
Tianjin Pharmaceutical Da Ren Tang Group
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Shenfuqiangxin is a traditional Chinese medicine (TCM) patent drug formulated as oral pills or capsules. It is primarily used for the treatment of chronic heart failure (CHF), especially in patients with heart-kidney Yang deficiency syndrome—a TCM diagnostic category characterized by symptoms such as palpitations, breathlessness, chest tightness, puffy face, and swollen limbs. The formulation contains multiple herbal ingredients including Ginseng (Renshen), Radix aconiti carmichaeli (Fuzi), rhubarb (Dahuang), root bark of white mulberry (Sangbaipi), Polyporus umbellata, Semen lepidii (Tinglizi), and grifola (Zhuling). Mechanistically, preclinical studies suggest that Shenfuqiangxin exerts cardioprotective effects by modulating several signaling pathways involved in cardiac hypertrophy and apoptosis—such as inhibiting the mitogen-activated protein kinase pathway and regulating Bcl-2/Bax expression to reduce cardiomyocyte apoptosis. It also appears to improve water-sodium retention and protect renal function. Clinical trials have evaluated its efficacy and safety in CHF patients alongside standard Western therapies[5][1][6][3].

Brand names
ShenfuqiangxinSFQX
Other names
Shenfu Qiangxin pillsShenfuqiangxin Capsule
02

Targets

CASP (Caspase family)TNFR (TNF receptor family)BAX (Apoptosis regulator BAX)

Beyond the preview

Go deeper on shenfuqiangxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenfuqiangxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call